RI-MUHC teams received $9.5 million in project funding

Researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) will embark on 17 new projects designed to accelerate discoveries of benefit to human health, thanks to the Canadian Institutes of Health Research (CIHR) Fall 2021 Project Grants Competition. The RI-MUHC teams received over $9.5 million in project funding.

Across Canada, the competition has approved 417 research grants plus one bridge grant for a total investment of approximately $325 million. In addition, 105 priority announcement grants were funded for a total amount of over $12 million and 13 supplemental prizes were awarded for a total of $400K.

The CIHR Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

“We are extremely proud of RI-MUHC grant recipients and their teams for rising to the challenges of the year with this resounding success at the national level,” says Dr. Rhian Touyz, Executive Director and Chief Scientific Officer, RI-MUHC. “Their newly funded projects reflect strengths across the biomedical research spectrum and will, beyond a doubt, lead to exciting developments in health care and the knowledge it relies on, for Canadians and for our global neighbours.”

Congratulations to RI-MUHC grant recipients and their teams!

Project Grants

  • Michal Abrahamowicz
    New statistical methods for population-based studies of time-varying drug exposures: development, validation, and real-world analyses of drug safety and effectiveness
  • Faiz Ahmad Khan, Frantz Jean-Louis, Kevin Schwartzman
    Chest Radiography and TB Elimination in Nunavik: novel solutions to fill gaps and strengthen regional capacity
  • Charles Bourque
    Mechanical basis for central dysautonomias following head injury in mice
  • Jun Ding
    Unagi: Computational approach driven repurposed drugs for idiopathic pulmonary fibrosis
  • David Labbé, François Bordeleau
    Protein glycation acts as a substrate-dependent tumorigenic molecular switch in prostate cancer
  • Nathalie Lamarche-Vane
    Investigating the mechanisms underlying the Rac1/Cdc42 GTPase regulator CdGAP in breast cancer
  • Keith Murai
    Astrocyte Nanostructure and Function in the Healthy and Diseased Brain
  • Basil Petrof
    Novel therapies for diaphragm failure in muscular dystrophy
  • Jean-Pierre Routy
    Reversing CMV-induced gut damage to reduce inflammation and improve response to vaccine in people living with HIV
  • Paul Sabatini
    Physiologic- and pathophysiologic-responsive brainstem neurons controlling appetite
  • Rima Slim
    Identify novel genes and mechanisms of molar pregnancies and reproductive failure
  • George Thanassoulis
    Addressing knowledge gaps in the use of lipoprotein testing in cardiovascular prevention

Priority announcements

  • Nathalie Lamarche-Vane
    Netrin-1 receptor "deleted in colorectal cancer" (DCC) signalosome in axonal development
  • Bertrand Lebouché, Kim Engler, Marie-Pascale Pomey, Tibor Schuster
    Implementation of a patient portal and tailored patient-reported outcome measures to improve health problem detection and retention in HIV care: The DRHIVE Study
  • Sara Ahmed, Claudine Auger, Michèle Bleau, Cindy Starnino, Gary Stoopler, Aliki Thomas
    Effectiveness of a customized digital platform to increase coordination of care and uptake of evidence based practices: A stepped-wedge design
  • Jean-Jacques Lebrun
    Defining the role of CDK6 and DNA repair pathways in tumorigenesis and identify CDK4/6-dependent synthetic lethal vulnerabilities in triple negative breast cancer

Priority announcement – Genetics (Bridge Funding: Research Priorities)

  • Sampath Loganathan
    Deciphering the role of metabolic genes in head and neck squamous cell carcinoma

Learn more on the Canadian Institutes of Health Research (CIHR) website

—Published February 10, 2022